SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.288+68.4%Jan 30 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cheeseburger who wrote (721)7/16/1999 1:49:00 AM
From: Pete NY  Read Replies (1) of 900
 
FYI...read some info on LIPO and will be doing more DD.

Profits estimated at $0.19 a share this year and $0.34 in 2000.

Anticipate FDA approval of EVACET by year end.

With $57 million in cash, Liposome possesses the critical funding to develop its existing drug pipeline and to obtain licenses for new products.

Profitable biopharmaceutical company has solid management and a proven technology platform.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News